Investigating the mechanisms of CD20 downregulation triggered by tyrosine kinase inhibitors in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
2023/49/N/NZ5/04272
Keywords
Descriptors
- NZ5_07: Leczenie chorób człowieka
- NZ6_01: Odporność swoista i nieswoista
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 22 – announced on 2023-03-16
- Amount awarded
- 204 906 PLN
- Project start date
- 2024-06-17
- Project end date
- 2027-06-16
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.